Outcomes by Clinical and Molecular Features in Children with Medulloblastoma Treated with Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03)

Amar Gajjar, Giles W. Robinson, Kyle S. Smith, Tong Lin, Thomas E. Merchant, Murali Chintagumpala, Anita Mahajan, Jack Su, Eric Bouffet, Ute Bartels, Tal Schechter, Tim Hassall, Thomas Robertson, Wayne Nicholls, Sridharan Gururangan, Kristin Schroeder, Michael Sullivan, Greg Wheeler, Jordan R. Hansford, Stewart J. KellieGeoffrey McCowage, Richard Cohn, Michael J. Fisher, Matthew J. Krasin, Clinton F. Stewart, Alberto Broniscer, Ivo Buchhalter, Ruth G. Tatevossian, Brent A. Orr, Geoff Neale, Paul Klimo, Frederick Boop, Ashok Srinivasan, Stefan M. Pfister, Richard J. Gilbertson, Arzu Onar-Thomas, David W. Ellison, Paul A. Northcott

Research output: Contribution to journal › Article › peer-review

116 Scopus citations

Fingerprint

Dive into the research topics of 'Outcomes by Clinical and Molecular Features in Children with Medulloblastoma Treated with Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03)'. Together they form a unique fingerprint.

Medicine & Life Sciences